InMode Ltd vs Prudential PLC — how do they compare? InMode Ltd trades at $15.2 (market cap $872.08M), while Prudential PLC trades at $27.51 (market cap $34.02B). The key difference: Prudential PLC is far larger — about 39× InMode Ltd's market cap, and Prudential PLC pays a 1.94% dividend while InMode Ltd pays none. Which is the better fit depends on your goals.
| INMD | PUK | |
|---|---|---|
Market Cap | $872.08M | $34.02B |
Sector | Technology | Financials |
52-Week High | $16.62 | $33.61 |
52-Week Low | $12.76 | $24.98 |
Enterprise Value | $375.42M | $35.46B |
Dividend Yield | — | 1.94% |
Signals from Pluang's Aura AI — not financial advice
InMode (INMD) trades at $15.17, down slightly by 0.13% today, with neutral technical signals and mixed earnings performance. The company maintains strong profitability with 76.52% gross margins and 20.69% net income margins, though Q1 2026 earnings missed expectations. Recent news highlights acquisition interest from Steel Partners at $16.75 per share and ongoing shareholder activism, creating both opportunity and uncertainty around corporate governance and valuation.
The stock presents a value opportunity with low P/E (12.52) and EV/EBITDA (5.37) multiples, but faces risks from earnings volatility, shareholder disputes, and potential undervaluation concerns. Analyst consensus leans neutral with 45% buy ratings, while technical indicators suggest range-bound trading near key support at $15. Investment appeal hinges on resolution of acquisition talks and sustained execution amid competitive pressures.
Prudential PLC (PUK) trades at $28.22, down 0.21% on the day, with a bearish technical signal from moving averages but a neutral oscillator stance. The stock shows strong fundamentals with a P/E of 8.92, net income margin of 14.52%, and ROE of 21.15%. Recent earnings beat expectations in Q4 2025, and cash flow from operations reached $3.61B in 2024. However, news of China taxing offshore insurance policies caused a recent sell-off, highlighting regulatory risks.
The outlook for PUK is mixed; solid profitability and low valuation metrics provide upside potential, supported by a 50% analyst buy rating. Key risks include exposure to Chinese regulatory changes and competitive pressures in Asia. Earnings growth and strategic focus on capital-light operations are catalysts, but investor sentiment remains cautious due to near-term headwinds.
Trailing returns across standard periods
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →